Home » Tenders » Americas » USA » Tender 140727930

Dow Multiple Sclerosis Clinical Trial Award Tender in USA - 140727930

The DEPT. OF THE ARMY -- USAMRAA has issued a Tender notice for the procurement of a Dow Multiple Sclerosis Clinical Trial Award in the USA. This Tender notice was published on 06 May 2026 and is scheduled to close on 13 Aug 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 140727930, while the tender notice number is HT942526MSRPCTA and Registering on the platform.

Procurement Summary

Country: USA

Summary: Dow Multiple Sclerosis Clinical Trial Award

Deadline: 13 Aug 2026

Posting Date: 06 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 140727930

Document Ref. No.: HT942526MSRPCTA

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

Summary: The Fiscal Year 2026 (Fy26) Multiple Sclerosis Research Program (Msrp) Clinical Trial Award (Cta) Supports The Rapid Implementation Of Clinical Trials With The Potential To Have A Significant Impact On The Treatment Or Management Of Multiple Sclerosis. All Applications Must Address At Least One Of The Fy26 Msrp Cta Focus Areas. Clinical Trials May Evaluate Promising New Products, Pharmacologic Agents (Drugs Or Biologics), Devices, Clinical Guidance And/Or Emerging Approaches And Technologies.Distinctive Features: The Fy26 Cta Offers Two Funding Levels. The Following Are Generalized Descriptions Of The Scope Of Research Appropriate For Each Funding Level:• Funding Level 1 (Cta-Fl1) Supports Small-Scale, Proof-Of-Principle Clinical Trials (E.G., Pilot, First-In-Human, Phase 0) To Demonstrate Feasibility Or Inform The Design Of More Advanced Trials, Or Other Clinical Trials That Are Appropriate For This Funding Level. Preliminary Data Relevant To The Proposed Clinical Trial Are Required.• Funding Level 2 (Cta-Fl2) Supports Larger-Scale Clinical Trials At Phase 1 Or Phase 2 That Seek To Show Preliminary Evidence Of Safety Or Efficacy (I.E., Benefit Of Clinical Or Paraclinical Outcomes) In Relevant Patient Populations. Clear Description And Justification Should Be Provided, Which Could Include, But Is Not Limited To, The Intervention Type, Trial Duration, Sample Size, Outcome Measures, Assessment Tools And Frequency Of Assessment. Preliminary Data Relevant To The Proposed...
Posted Date: 2026-05-05 00:00:00

Funding instrument type: Grant

Documents

Tender Notice

Browse More

All Tenders From USA

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By